Skip to content

Transversus Abdominis Plane Blocks With Abdominoplasty

Transversus Abdominis Plane Blocks in Patients Scheduled for an Abdominoplasty. A Prospective, Randomized, Double Blind, Comparison Between the Posterior Approach and Placebo.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01278264
Acronym
TAPA
Enrollment
60
Registered
2011-01-17
Start date
2011-06-30
Completion date
2012-08-31
Last updated
2011-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain

Keywords

Transversus abdominis plane block, Ultrasound guided, Abdominoplasty

Brief summary

Comparing morphine consumption and recovery with two different TAP block techniques after abdominoplasty.

Detailed description

TAP blocks have the potential to become an important part of multi-modal analgesia after abdominal surgery (1,2). Originally Dr J McDonnell described a blind double pop technique, trough the triangle of Petit, with up to 48 hours of analgesia (3,4). Dr P Hebbard described an ultrasound based technique with a subcostal (for supra-umbilical analgesia) and an axillary mid-line injection (for sub-umbilical analgesia) in the TAP, with reported analgesia for up to 8 hours (5,6). Recently Dr J McDonnell presented data showing para vertebral spread (up to L5) of the (high dose, low concentration) local anaesthetic explaining the prolonged analgesic effect (7,8). In 2007 Dr Blanco described an ultrasound guided technique for the posterior infiltration as performed by McDonnell (9). Our limited observational comparison between both block techniques confirms this difference. We decided to compare both techniques (the ultrasound guided single shot subcostal injection, the aTAP-group (Hebbard is from Australia) and the ultrasound guided posterior injection, the iTAP-group (McDonnell is from Ireland). We will use the same volume and concentration of local anesthetic and we will asses their analgesic efficacy and improvement in quality of recovery.

Interventions

DRUGRopivacaine 0.25%, 0.5 ml/kg

Posterior approach for TAP: ultrasound guided bilateral needle insertion in the transversus abdominis plane, anterior to the quadratus lumborum muscle

Sponsors

Clinique Saint-Jean, Bruxelles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Eligible for abdominoplasty * ASA 1-2 * Fluent french/dutch/english

Exclusion criteria

* History of allergy to local anaesthetics * Chronic opioids abuse * Pregnant patients

Design outcomes

Primary

MeasureTime frameDescription
Morphine consumption48 hoursConsumption measured by the use of the PCA pump

Secondary

MeasureTime frame
Post operative nausea and vomiting48 hours
Constipation48 hours
VAS score48 hours
First time to get up48 hours
First time to eat48 hours
Pruritus48 hours

Countries

Belgium

Contacts

Primary ContactArnaud G Bosteels, MD
Abosteels@clstjean.be02 221 97 62

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026